Who We Are

FendX Technologies Inc. is a nanotechnology company focused on developing products to make people’s lives safer by keeping surfaces clean. The Company is developing novel protective nano-coatings that significantly reduce bacteria, viruses, blood and other liquids from sticking to the surface.

Our Vision

Advancing nanotechnology to contribute to controlling the spread of pathogens.

Our Mission

To relentlessly innovate and develop nanotechnology solutions to make people's lives safer from the spread of pathogens.

Core Values

This tab is a default hidden tab.

Innovation: We foster a culture of continuous exploration, pushing the boundaries of nanotechnology to create groundbreaking solutions for infectious disease control.

Collaboration: We believe in the power of partnerships. By working together with researchers, manufacturers, and other experts, we amplify our impact.

Passion: We approach our work with unwavering enthusiasm and dedication. Our love for advancing nanotechnology and combating infectious diseases fuels our commitment to making a difference. passion propels us forward, even in the face of challenges.

Excellence: We strive for excellence in research, product development, and implementation. Quality is our hallmark.

Making a difference: We are driven by the belief that every action, no mater how small, contributes to positive change. We strive to leave a lasting impact on global health, one breakthrough at a time.

Featured in the media

“FendX Nanotechnology Innovations in Surface Protection …“

“The healthcare world needs innovative solutions like these to contribute to the global efforts to reduce the spread of potentially deadly microbes.”

“REPELWRAPTM has the potential to make a substantial impact not only in healthcare but also in other high-traffic, high-touch point industries…”

“Their surface coatings in development provide instant and continuous protection…”

“Researchers have developed a self-cleaning plastic wrap that repels bacteria and could be used to prevent the transfer of antibiotic resistant superbugs, and other forms of dangerous bacteria.”

Management

Dr. Carolyn Myers MBA, PhD

President, CEO & Director

Rose Zanic CPA, CA

CFO & Corporate Secretary

Tash Yousuf BSc

Senior Operations Manager

Nanotechnology: The Potential to Create a Safer Tomorrow

Nanotechnology, with its innovative approaches, holds the promise of revolutionizing infectious disease control management by enhancing prevention strategies, diagnostics and drug delivery, ultimately contributing to global health. At FendX, we believe the products we are developing using our nanotechnology will contribute to creating safer and more hygienic environments, particularly in the face of very difficult to control potentially lethal pathogens.

Careers At FendX

Do you want to make a difference? Are you an innovative, collaborative and passionate leader?

Come join FendX, a company with career growth opportunities.

Dr. Carolyn Myers MBA, PhD

President, CEO & Director
  • Principal of BioEnsemble LLC, assisting start-ups and small pharma companies in developing their business strategy and planning
  • Vice President International Business Development and Alliance Management at Allergan PLC (market cap $83 Bn, 2017, now Abbvie),
  • President of Dey Laboratories and President of Mylan Technologies Inc. (market cap $9.2 Bn, 2011, now Viatris Inc.)
  • Senior management at Pharmacia Corporation (now Pfizer)
  • Director Hyloris Pharmaceuticals SA (BR:HYL), EyeD Pharma (private)

Rose Zanic CPA, CA

CFO & Corporate Secretary
  • Over 25 years of capital markets and corporate finance expertise
  • Significant experience advising Canadian public companies with financing, M&A transactions and providing public company administration.
  • Previously Senior Vice-President, Corporate Finance at Wolverton Securities Ltd.
  • Experience as a director and/or officer with several Canadian publicly listed companies
  • Member of the TSX Venture Exchange BC Local Advisory Committee

Tash Yousuf BSc

Senior Operations Manager
  • Expertise in project and operations management
  • Oversees business operations and product development, driving FendX’s key projects forward
  • Software Project Coordinator at Lenbrook International
  • Operations Manager at Cineplex VIP Cinemas

Dr. Carolyn Myers MBA, PhD

President, CEO & Director

Stephen Randall CPA, CGA

Independent Board Member & Audit Committee Chair
  • Senior financial manager and Director with over 40 years’ experience.
  • Served in senior financial roles with both private, publicly traded and start-up companies in the manufacturing, telecommunications, technology, and medical device sectors.
  • Former Board Member, CFO and Corporate Secretary of Titan Medical Inc (TSX: TMD and NASDAQ: TMDI)

Pierre Soulard B.C.L., LLB, LLM

Independent Board Member
  • Former Chief Legal Officer of CoinSmart (NEO: SMRT)
  • Former partner, at Miller Thomson, a leading Canadian law firm.
  • Focused on securities law, corporate finance, mergers and acquisitions and corporate governance for a wide range of national and international issuers and investors.